No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek, Ismail
No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. [electronic resource] - Journal of nephrology - 119-23 p. digital
Publication Type: Case Reports; Journal Article
1121-8428
Adult
Amyloidosis--complications
Biopsy
Etanercept
Familial Mediterranean Fever--complications
Follow-Up Studies
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Kidney--metabolism
Male
Nephrotic Syndrome--drug therapy
Receptors, Tumor Necrosis Factor--antagonists & inhibitors
Serum Amyloid P-Component--metabolism
Treatment Outcome
No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. [electronic resource] - Journal of nephrology - 119-23 p. digital
Publication Type: Case Reports; Journal Article
1121-8428
Adult
Amyloidosis--complications
Biopsy
Etanercept
Familial Mediterranean Fever--complications
Follow-Up Studies
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Kidney--metabolism
Male
Nephrotic Syndrome--drug therapy
Receptors, Tumor Necrosis Factor--antagonists & inhibitors
Serum Amyloid P-Component--metabolism
Treatment Outcome